<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A transformation of <z:e sem="disease" ids="C0040028" disease_type="Disease or Syndrome" abbrv="">essential thrombocythemia</z:e> to <z:hpo ids='HP_0004808'>acute myelocytic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, or agnogenic myelocytic <z:mpath ids='MPATH_160'>metaplasia</z:mpath> is a relatively rare event </plain></SENT>
<SENT sid="1" pm="."><plain>It occurs in 1%-4.5% of <z:hpo ids='HP_0000001'>all</z:hpo> patients with either treated or untreated <z:e sem="disease" ids="C0040028" disease_type="Disease or Syndrome" abbrv="">essential thrombocythemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Cytogenetic changes in the transformation to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> are common </plain></SENT>
<SENT sid="3" pm="."><plain>We report the case of a patient treated for <z:e sem="disease" ids="C0040028" disease_type="Disease or Syndrome" abbrv="">essential thrombocythemia</z:e> with <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi> for 49 months </plain></SENT>
<SENT sid="4" pm="."><plain>He developed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with a t(2;17), which to our knowledge has not been described in the literature </plain></SENT>
</text></document>